📊 A Look at the Evidence for Fat Loss
The story of AOD9604's effectiveness is conflicting.
Early Promise: Initial clinical trials showed some positive results. One 12-week study reported that participants taking a 1mg dose of AOD9604 lost an average of 2.8 kg, which was more than triple the weight lost by those on a placebo (who lost an average of 0.8 kg). The drug was also reported to be well-tolerated, with a safety profile similar to a placebo.
Conflicting & Discontinued Research: Despite these initial findings, the development and major trials of AOD9604 for obesity were stopped in 2007. A lead researcher involved in the trials later stated that the drug had no proven anti-obesity effects and showed "no clinically meaningful weight loss outcome". This significant contradiction casts a long shadow over the earlier positive results.
⚙️ How It's Supposed to Work
AOD9604 is a synthetic peptide, a fragment derived from the human growth hormone (HGH) molecule. It was designed to mimic HGH's effect on fat metabolism (specifically lipolysis, the breakdown of fat) without the serious side effects often associated with full HGH therapy, such as blood sugar issues and insulin resistance.
https://www.hormonerawsource.com/peptides/superior-quality-aod9604-peptides-powder-for.html
